npr glp 1 DR. BETSY DOVEC, #1 female weight loss surgeon and founder of @bodybybariatrics // interviewed with @npr for a radio interview and digital article on the topic of GLP-1s. Read the full interview Many people start and stop

For practitioners treating GLP-1 agonist non-responders, understanding these biological adaptations proves essential, as they explain why willpower alone rarely suffices for sustainable results

The first cohort comprised individuals who started and continued either a GLP-1 receptor agonist or DPP-4 inhibitor for the first time between January 1, 2007, and December 31, 2020

The market for obesity drugs is also expected to reach US$ 50 billion by 2030

ColonBroom GLP-1 Booster is a dietary supplement, not a medication

In a statement, Attorney General Ken Paxton accuses Eli Lilly of using illegal practices, such as offering free nurses and reimbursement support services for doctors who prescribed Zepbound

By staying proactive and patient-centric, providers can help patients continue their weight-loss journey safely and effectively. Patients may feel frustrated, confused or anxious about losing access to medications that were working for them